Bausch Health investigated by US Department of Justice over misleading marketing
Three plaque psoriasis drugs and one fungal treatment are the suspects in a case concerning wrongful marketing by Canadian pharmaceutical firm Bausch Health, and the US Department of Justice is reportedly looking into the matter.
by christian bundgaard, translated by daniel pedersen
Bausch Health has run into problems with the US authorities, as the Canadian company is being investigated for having marketed three plaque psoriasis treatments and one fungal treatment for unintended use, media Endpoints News reports based on a Stat News story.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
GN denies involvement in false advertising case
For subscribers
WS Audiology and GN settle false advertising case in US
For subscribers
.jpg&w=384&q=75)
